Sign Up to like & get
recommendations!
0
Published in 2019 at "Current cancer drug targets"
DOI: 10.2174/1568009618666171129222159
Abstract: Trastuzumab is a humanized monoclonal antibody that is approved for the treatment of breast and gastric malignancies. Although it has shown promise as a biotherapeutic, its cardiotoxicity remains a major concern. Genotoxic anticancer anthracyclines such…
read more here.
Keywords:
trastuzumab;
toxicology trastuzumab;
cardiotoxicity;
cardiotoxic effects ... See more keywords